Finance

Lists
Why is CBI down 2,25%?
Dive Deeper
CBI:TLV
Clal Biotechnology Industries Ltd.
ILA 21,70
-2,25%
(-0,50) 1D
20 Okt., 17:26:00 GMT+3  ·   ILA
All symbols
SymbolPriceChange% Change
Generating top insights for CBI...
Open
ILA 22,20
High
ILA 23,80
Low
ILA 21,30
Mkt. cap
34,04 m
Avg. vol.
80,22 k
Volume
167,17 k
52-wk high
ILA 36,00
52-wk low
ILA 21,30
EPS
-ILA 0,06
Shares outstanding
156,85 m
No. of employees
3
Open
ILA 22,20
High
ILA 23,80
Low
ILA 21,30
Mkt. cap
34,04 m
Avg. vol.
80,22 k
Volume
167,17 k
52-wk high
ILA 36,00
52-wk low
ILA 21,30
EPS
-ILA 0,06
Shares outstanding
156,85 m
No. of employees
3
News stories
From web sources and news partners
About Clal Biotechnology Industries Ltd.
CEO-
Employees3
Founded1998
Headquarters-
Sector-
Websitecbi.co.il
Previous reportsAll values in ILS
Loading Previous Earnings...
Revenue
Net income
All values in ILS
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,01 m
1,01 m
872,50 k
872,50 k
Operating expense
1,12 m
1,12 m
798,50 k
798,50 k
Total operating expenses
1,12 m
1,12 m
798,50 k
798,50 k
Operating income
-1,12 m
-1,12 m
-798,50 k
-798,50 k
Other non operating income
-28,00 k
-28,00 k
-94,50 k
-94,50 k
EBT including unusual items
-4,52 m
-4,52 m
-3,14 m
-3,14 m
EBT excluding unusual items
-3,33 m
-3,33 m
-3,01 m
-3,01 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-74,00 k
-74,00 k
Net income
-1,48 m
-1,48 m
-2,94 m
-2,94 m
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
114,00 k
114,00 k
204,00 k
204,00 k
Interest expense
-
-
-21,50 k
-21,50 k
Net interest expenses
114,00 k
114,00 k
182,50 k
182,50 k
Depreciation and amortization charges
108,00 k
108,00 k
-
-
EBITDA
-1,07 m
-1,07 m
-766,00 k
-766,00 k
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme